AU2003218234A1 - Methods of expressing non-endogenous g protein coupled receptors in cells - Google Patents

Methods of expressing non-endogenous g protein coupled receptors in cells

Info

Publication number
AU2003218234A1
AU2003218234A1 AU2003218234A AU2003218234A AU2003218234A1 AU 2003218234 A1 AU2003218234 A1 AU 2003218234A1 AU 2003218234 A AU2003218234 A AU 2003218234A AU 2003218234 A AU2003218234 A AU 2003218234A AU 2003218234 A1 AU2003218234 A1 AU 2003218234A1
Authority
AU
Australia
Prior art keywords
endogenous
cells
methods
protein coupled
coupled receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003218234A
Other versions
AU2003218234A8 (en
Inventor
John Adams
Derek Chalmers
Martin Gore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arena Pharmaceuticals Inc
Original Assignee
Arena Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharmaceuticals Inc filed Critical Arena Pharmaceuticals Inc
Publication of AU2003218234A8 publication Critical patent/AU2003218234A8/en
Publication of AU2003218234A1 publication Critical patent/AU2003218234A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003218234A 2002-03-15 2003-03-11 Methods of expressing non-endogenous g protein coupled receptors in cells Abandoned AU2003218234A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36449102P 2002-03-15 2002-03-15
US60/364,491 2002-03-15
PCT/US2003/008276 WO2003078602A2 (en) 2002-03-15 2003-03-11 Methods of expressing non-endogenous g protein coupled receptors in cells

Publications (2)

Publication Number Publication Date
AU2003218234A8 AU2003218234A8 (en) 2003-09-29
AU2003218234A1 true AU2003218234A1 (en) 2003-09-29

Family

ID=28041923

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003218234A Abandoned AU2003218234A1 (en) 2002-03-15 2003-03-11 Methods of expressing non-endogenous g protein coupled receptors in cells

Country Status (2)

Country Link
AU (1) AU2003218234A1 (en)
WO (1) WO2003078602A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1882689A (en) * 2003-11-21 2006-12-20 艾尼纳制药公司 Methods for producing olfactory GPCRs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
JP2002507422A (en) * 1998-03-23 2002-03-12 スミスクライン ビーチャム コーポレーション Human G protein-coupled receptor GPR6sb
DK1095275T3 (en) * 1998-07-31 2009-09-28 Arena Pharm Inc Endogenous, constitutively activated G protein-coupled orphan receptors
MXPA01008618A (en) * 1999-02-26 2002-03-20 Arena Pharm Inc Small molecule modulators of g protein-coupled receptor six.

Also Published As

Publication number Publication date
WO2003078602A2 (en) 2003-09-25
WO2003078602A3 (en) 2004-04-01
AU2003218234A8 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
WO2004040000A9 (en) G protein coupled receptors and uses thereof
AU2003290321A1 (en) Cell cycle progression proteins
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003302820A1 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
AU2003901316A0 (en) Regulation of cell surface proteins
AU2003218234A1 (en) Methods of expressing non-endogenous g protein coupled receptors in cells
AU2003251531A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002321440A1 (en) Expression of modified antibodies in avian cells
AU2003295824A1 (en) Cell adhesion and extracellular matrix proteins
AU2003265431A1 (en) Cell adhesion and extracellular matrix proteins
AU2003298029A1 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
AU2003230671A1 (en) Improvements in electrochemistry
EP1563073A4 (en) Protein production methods and modified cells for use therein
AU2003228872A1 (en) Cell adhesion and extracellular matrix proteins
AU2003202694A1 (en) Torero protein
AU2003297696A1 (en) Compositions,splice variants and methods relating to breast specific genes and proteins
AU2003216475A1 (en) Human schwannoma cell line
AU2003272799A1 (en) Receptors and membrane-associated proteins
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003280643A1 (en) Membrane protein originating in mast cells
AU2003295437A1 (en) Receptors and membrane-associated proteins
AU2003297703A1 (en) Compositions, splice variants and methods relating to prostate specific genes and proteins
AU2003300785A1 (en) Carbohydrate-associated proteins
AU2003253675A1 (en) Methods for protein analyses and protein expression in multicellular organisms and cells therefrom

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase